This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: University of Colorado, National Jewish Health, University of Florida Research Foundation Inc.. Active years: 2014-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 1,450 
1 out of 90 
1 out of 3,056 
Years Active: 2014-2018
Title: George S Eisenbarth: Innovator in Autoimmunity Detection
Introduction
George S Eisenbarth, based in Golden, Colorado, is a notable inventor recognized for his groundbreaking contributions in the field of autoimmunity and diabetes diagnostics. With a total of three patents to his name, his work focuses on innovative methods to predict and manage autoimmune diseases, particularly Type 1 diabetes.
Latest Patents
Eisenbarth's most recent patent, "Methods for detecting insulin autoantibody," outlines techniques that can be utilized to assess the susceptibility to and diagnose the onset of Type 1 diabetes in subjects. This invention introduces kits designed for such detection methods, employing proinsulin as a key element in identifying insulin autoantibodies. Another significant invention titled "Compounds that modulate autoimmunity and methods of using the same" presents methods to prevent and treat autoimmune conditions, including diabetes and celiac disease. This innovation focuses on decreasing the affinity of MHC class II molecules to antigenic peptides, utilizing small organic compounds as therapeutic agents.
Career Highlights
Eisenbarth has made significant contributions while working at prestigious institutions such as the University of Colorado and the University of Florida Research Foundation. His research is paramount in advancing our understanding of autoimmune disorders and developing effective treatments.
Collaborations
Throughout his career, Eisenbarth has collaborated with esteemed colleagues, including Aaron Michels and Maki Nakayama. These collaborations have been instrumental in enhancing the research quality and broadening the impact of their findings in the scientific community.
Conclusion
George S Eisenbarth stands out as an influential figure in the realm of medical innovation, particularly in the diagnoses and treatment of autoimmune diseases. His advancements not only push the boundaries of scientific research but also pave the way for improved patient outcomes in managing Type 1 diabetes and related conditions. As he continues to innovate, his work remains a valuable asset to both the scientific and broader health communities.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile